Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death

International Journal of Pharmaceutics

Volumn 454, Issue 2, 2013, Pages 765-774

  Griveau, A ^a,b   Bejaud, J ^a,b   Anthiya, S ^a,b   Avril, S ^a,b   Autret, D ^c   Garcion, E ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b LUNAM Universite   (France)

^c Institut de Cancérologie de l'Ouest ^*  (France)

Author keywords

Glioblastoma; Lipid nanocapsules; Locked nucleic acid; MicroRNA; Radiotherapy

Indexed keywords

LOCKED NUCLEIC ACID; MICRORNA 21; NANOCARRIER; SOLID LIPID NANOPARTICLE;

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL DEATH; CELL SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NANOMEDICINE; PEPTIDE SYNTHESIS; PHYSICAL CHEMISTRY; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; RADIATION INDUCED CELL DEATH; RADIOSENSITIZATION; RNA EXTRACTION;

GLIOBLASTOMA; LIPID NANOCAPSULES; LOCKED NUCLEIC ACID; MICRORNA; RADIOTHERAPY;

CELL DEATH; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; LECITHINS; LIPOPEPTIDES; MICRORNAS; NANOCAPSULES; OLIGONUCLEOTIDES; POLYETHYLENE GLYCOLS; RNA INTERFERENCE; STEARIC ACIDS; TRIGLYCERIDES;

EID: 84884133889     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.05.049     Document Type: Article

References (46)

1. Allard, E., Passirani, C., Garcion, E., Pigeon, P., Vessieres, A., Jaouen, G., Benoit, J.P., 2008. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas. J. Control. Release 130, 146-153.
2. Anton, N., Mojzisova, H., Porcher, E., Benoit, J.P., Saulnier, P., 2010. Reverse micelle-loaded lipid nano-emulsions: new technology for nano-encapsulation of hydrophilic materials. Int. J. Pharm. 398, 204-209.
3. Ballot, S., Noiret, N., Hindre, F., Denizot, B., Garin, E., Rajerison, H., Benoit, J.P., 2006. 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution. Eur. J. Nucl. Med. Mol. Imaging 33, 602-607.
4. Bartel, D.P., 2009. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
5. Beduneau, A., Hindre, F., Clavreul, A., Leroux, J.C., Saulnier, P., Benoit, J.P., 2008. Brain targeting using novel lipid nanovectors. J. Control. Release 126, 44-49. (Pubitemid 351175685)
6. Bourseau-Guilmain, E., Bejaud, J., Griveau, A., Lautram, N., Hindre, F., Weyland, M., Benoit, J.P., Garcion, E., 2012. Development and characterization of immunonanocarriers targeting the cancer stem cell marker AC133. Int. J. Pharm. 423, 93-101.
7. Bousarghin, L., Touze, A., Combita-Rojas, A.L., Coursaget, P., 2003. Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor. J. Gen. Virol. 84, 157-164. (Pubitemid 36113561)
8. Broderick, J.A., Zamore, P.D., 2011. MicroRNA therapeutics. Gene Ther. 18, 1104-1110.
9. Calin, G.A., Croce, C.M., 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866. (Pubitemid 44629897)
10. Carthew, R.W., Sontheimer, E.J., 2009. Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655.
11. Chan, J.A., Krichevsky, A.M., Kosik, K.S., 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029-6033. (Pubitemid 40994386)
12. Corsten, M.F., Miranda, R., Kasmieh, R., Krichevsky, A.M., Weissleder, R., Shah, K., 2007. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 67, 8994-9000. (Pubitemid 47535880)
13. Dong, H., Ding, L., Yan, F., Ji, H., Ju, H., 2011. The use of polyethylenimine-grafted graphene nanoribbon for cellular delivery of locked nucleic acid modified molecular beacon for recognition of microRNA. Biomaterials 32, 3875-3882.
14. Elmen, J., Lindow, M., Schutz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjarn, M., Hansen, H.F., Berger, U., Gullans, S., Kearney, P., Sarnow, P., Straarup, E.M., Kauppinen, S., 2008. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899. (Pubitemid 351550859)
15. Esquela-Kerscher, A., Slack, F.J., 2006. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
16. Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M.C., Martelli, F., 2008. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. J. Biol. Chem. 283, 15878-15883.
17. Garcion, E., Lamprecht, A., Heurtault, B., Paillard, A., Aubert-Pouessel, A., Denizot, B., Menei, P., Benoit, J.P., 2006. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol. Cancer Ther. 5, 1710-1722. (Pubitemid 44323239)
18. Grossman, S.A., Batara, J.F., 2004. Current management of glioblastoma multiforme. Semin. Oncol. 31, 635-644. (Pubitemid 39389014)
19. Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., 2002. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19, 875-880. (Pubitemid 34692585)
20. Huang, X., Le, Q.T., Giaccia, A.J., 2010. MiR-210 - micromanager of the hypoxia pathway. Trends Mol. Med. 16, 230-237.
21. Kurreck, J., Wyszko, E., Gillen, C., Erdmann, V.A., 2002. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 30, 1911-1918. (Pubitemid 34537585)
22. Lacoeuille, F., Garcion, E., Benoit, J.P., Lamprecht, A., 2007. Lipid nanocapsules for intracellular drug delivery of anticancer drugs. J. Nanosci. Nanotechnol. 7, 4612-4617.
23. Lanford, R.E., Hildebrandt-Eriksen, E.S., Petri, A., Persson, R., Lindow, M., Munk, M.E., Kauppinen, S., Orum, H., 2009. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201.
24. Lee, R.C., Feinbaum, R.L., Ambros, V., 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854. (Pubitemid 24014542)
25. Li, T., Cao, H., Zhuang, J., Wan, J., Guan, M., Yu, B., Li, X., Zhang, W., 2010. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin. Chim. Acta 412, 66-70.
26. Malzkorn, B., Wolter, M., Liesenberg, F., Grzendowski, M., Stuhler, K., Meyer, H.E., Reifenberger, G., 2010. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 20, 539-550.
27. Novakova, J., Slaby, O., Vyzula, R., Michalek, J., 2009. MicroRNA involvement in glioblastoma pathogenesis. Biochem. Biophys. Res. Commun. 386, 1-5.
28. Paillard, A., Hindre, F., Vignes-Colombeix, C., Benoit, J.P., Garcion, E., 2010. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials 31, 7542-7554.
29. Pang, J.C., Kwok, W.K., Chen, Z., Ng, H.K., 2009. Oncogenic role of microRNAs in brain tumors. Acta Neuropathol. 117, 599-611.
30. Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., 2007. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760. (Pubitemid 350223348)
31. Pounder, R.J., Stanford, M.J., Brooks, P., Richards, S.P., Dove, A.P., 2008. Metal free thiol-maleimide 'Click' reaction as a mild functionalisation strategy for degradable polymers. Chem. Commun. (Camb), 5158-5160.
32. Raouane, M., Desmaele, D., Urbinati, G., Massaad-Massade, L., Couvreur, P., 2012. Lipid conjugated oligonucleotides: a useful strategy for delivery. Bioconjug. Chem. 23, 1091-1104.
33. Roger, E., Lagarce, F., Garcion, E., Benoit, J.P., 2009. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J. Control. Release 140, 174-181.
34. Roger, E., Lagarce, F., Garcion, E., Benoit, J.P., 2010a. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (Lond) 5, 287-306.
35. Roger, E., Lagarce, F., Garcion, E., Benoit, J.P., 2010b. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells. Eur. J. Pharm. Sci. 40, 422-429.
36. Shi, S.J., Zhong, Z.R., Liu, J., Zhang, Z.R., Sun, X., Gong, T., 2012. Solid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cells. Pharm. Res. 29, 97-109.
37. Silber, J., James, C.D., Hodgson, J.G., 2009. microRNAs in gliomas: small regulators of a big problem. Neuromolecular Med. 11, 208-222.
38. Stenvang, J., Kauppinen, S., 2008. MicroRNAs as targets for antisense-based therapeutics. Expert Opin. Biol. Ther. 8, 59-81. (Pubitemid 351233723)
39. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R.C., Ludwin, S.K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J.G., Eisenhauer, E., Mirimanoff, R.O., 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996. (Pubitemid 40349501)
40. Tan, X., Wang, S., Yang, B., Zhu, L., Yin, B., Chao, T., Zhao, J., Yuan, J., Qiang, B., Peng, X., 2012. The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells. PLoS ONE 7, e49570.
41. Tarahovsky, Y.S., Koynova, R., MacDonald, R.C., 2004. DNA release from lipoplexes by anionic lipids: correlation with lipid mesomorphism, interfacial curvature, and membrane fusion. Biophys. J. 87, 1054-1064. (Pubitemid 39095084)
42. Vanpouille-Box, C., Lacoeuille, F., Roux, J., Aube, C., Garcion, E., Lepareur, N., Oberti, F., Bouchet, F., Noiret, N., Garin, E., Benoit, J.P., Couturier, O., Hindre, F., 2011. Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model. PLoS ONE 6, e16926.
43. Vinchon-Petit, S., Jarnet, D., Paillard, A., Benoit, J.P., Garcion, E., Menei, P., 2009. In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy. J. Neurooncol. 97, 195-205.
44. Vrignaud, S., Benoit, J.P., Saulnier, P., 2011. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials 32, 8593-8604.
45. Weyland, M., Manero, F., Paillard, A., Gree, D., Viault, G., Jarnet, D., Menei, P., Juin, P., Chourpa, I., Benoit, J.P., Gree, R., Garcion, E., 2011. Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1. J. Control. Release 151, 74-82.
46. Zhang, J., Han, L., Ge, Y., Zhou, X., Zhang, A., Zhang, C., Zhong, Y., You, Y., Pu, P., Kang, C., 2010. miR-221/222 promote malignant progression of glioma through activation of the Akt pathway. Int. J. Oncol. 36, 913-920.